Abbott Laboratories (ABT)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 5,723,000 5,162,000 5,161,000 5,804,000 6,933,000 7,889,000 8,554,000 7,725,000 7,071,000 7,244,000 6,376,000 5,724,000 4,495,000 3,382,000 3,110,000 3,579,000 3,687,000 3,292,000 2,895,000 2,622,000
Total assets US$ in thousands 73,214,000 72,090,000 73,354,000 73,794,000 74,438,000 72,801,000 74,202,000 74,007,000 75,196,000 73,795,000 73,269,000 72,785,000 72,548,000 69,043,000 68,776,000 66,777,000 67,887,000 68,539,000 68,427,000 67,610,000
ROA 7.82% 7.16% 7.04% 7.87% 9.31% 10.84% 11.53% 10.44% 9.40% 9.82% 8.70% 7.86% 6.20% 4.90% 4.52% 5.36% 5.43% 4.80% 4.23% 3.88%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $5,723,000K ÷ $73,214,000K
= 7.82%

Abbott Laboratories' return on assets (ROA) has been trending downwards over the past eight quarters, starting at 10.44% in Q1 2022 and decreasing to 7.82% in Q4 2023. The ROA values have fluctuated between 7.04% and 11.53% during this period, indicating some volatility in the company's ability to generate profits relative to its total assets. Overall, the decreasing trend in ROA suggests that Abbott Laboratories may be experiencing challenges in efficiently utilizing its assets to generate profits. Further evaluation of the company's asset management and profitability strategies may be necessary to address the decline in ROA.


Peer comparison

Dec 31, 2023


See also:

Abbott Laboratories Return on Assets (ROA) (Quarterly Data)